NATH BIOGENES (INDIA)
Back to Cashflow Statement
|
NATH BIOGENES (INDIA) Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2013 | |
|---|---|---|---|---|---|
| Cash Flow from Investing Activities | ₹-3.96 Cr | ₹-27 Cr | ₹-2.88 Cr | ₹-20 Cr | ₹-21 Cr |
What is the latest Cash Flow from Investing Activities ratio of NATH BIOGENES (INDIA) ?
| Year | Cash Flow from Investing Activities |
|---|---|
| Mar2025 | ₹-3.96 Cr |
| Mar2024 | ₹-27 Cr |
| Mar2023 | ₹-2.88 Cr |
| Mar2022 | ₹-20 Cr |
| Mar2013 | ₹-21 Cr |
How is Cash Flow from Investing Activities of NATH BIOGENES (INDIA) Trending?
| Years | Cash Flow from Investing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-3.96 Cr | Negative | |
| Mar2024 | ₹-27 Cr | Negative | |
| Mar2023 | ₹-2.88 Cr | Negative | |
| Mar2022 | ₹-20 Cr | Negative | |
| Mar2013 | ₹-21 Cr | - | |
Compare Cash Flow from Investing Activities of peers of NATH BIOGENES (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATH BIOGENES (INDIA) | ₹282.3 Cr | -1.6% | -11.8% | -27.8% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹13,011.4 Cr | 0.3% | -2.3% | -22.7% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,999.1 Cr | -2% | -3.5% | -2.2% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,181.6 Cr | 3.1% | 2.5% | -24.2% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹1,023.8 Cr | -8.2% | -20.6% | -40.5% | Stock Analytics | |
| INDO US BIOTECH | ₹249.0 Cr | -3% | -1.4% | -58.7% | Stock Analytics | |
NATH BIOGENES (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATH BIOGENES (INDIA) | -1.6% |
-11.8% |
-27.8% |
| SENSEX | -0.6% |
1.7% |
4.6% |
You may also like the below Video Courses